EAM Investors’s Sight Sciences SGHT Stock Holding History

EAM Investors’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-163,866	Closed	-$1.3M	–	366
2025 Q4	$1.3M	Buy	+163,866	New	+$1.05M	0.14%	182

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

EAM Investors's SGHT Position: Q1 2026 in Review

EAM Investors sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 163,866 shares — an estimated $1.3M sold.

EAM Investors first reported a position in SGHT in Q4 2025 and held it in 1 quarter. The position peaked at $1.3M in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

EAM Investors reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
EAM Investors sold 163,866 Sight Sciences shares in Q1 2026, an estimated $1.3M.
EAM Investors first reported a position in Sight Sciences in Q4 2025 and held it in 1 quarter.
EAM Investors's Sight Sciences position peaked at $1.3M in Q4 2025.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.